Agios Pharmaceuticals, Inc.

NASDAQ:AGIO

Biotechnology

Healthcare
$28.76 +1.50%

+$0.50 today

Market cap
$1.72B
Beta
0.59
P/E (TTM)
-4.7
EPS (TTM)
-$7.19
52W Low $22.24High $46.00

Volume 0.47M

Average 1.11M

Balance Sheet

Inspect the capital base behind the business.

Assets

$1.30B

FY 2025 · Annual

-22.0% YoY

Liabilities

$104.11M

FY 2025 · Annual

-14.8% YoY

Equity

$1.19B

FY 2025 · Annual

-22.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents203.13M139.26M88.21M76.25M89.13M
Short-term Investments816.89M643.86M688.72M817.46M765.3M
Net Receivables4.38M2.21M2.81M4.11M10.58M
Inventory08.49M19.08M27.62M32.92M
Other Current Assets038.96M35.02M40.17M44.13M
Total Current Assets1.06B832.77M833.84M965.6M942.05M
Property, Plant & Equipment (Net)104.23M88.12M69.79M54.55M41.23M
Goodwill00000
Intangible Assets00000
Long-term Investments266.38M313.87M29.44M638.32M310.01M
Tax Assets00000
Other Non-current Assets2.9M3.96M4.06M4.72M3.93M
Total Non-current Assets373.51M405.95M103.28M697.6M355.17M
Total Assets1.44B1.24B937.12M1.66B1.3B
Account Payables16.7M18.62M9.78M16.64M18.36M
Short-term Debt000018.39M
Tax Payables000871K0
Deferred Revenue00000
Other Current Liabilities19.82M12.25M23.23M29.94M18.2M
Total Current Liabilities59.83M62.63M67.96M81.16M82.21M
Long-term Debt000021.82M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities03.28M1.16M880K(21.73M)
Total Non-current Liabilities85.94M75.28M58.14M41.09M21.91M
Total Liabilities145.76M137.9M126.1M122.24M104.11M
Common Stock71K71K72K73K75K
Retained Earnings(238.76M)(470.56M)(822.65M)(148.92M)(561.71M)
Accumulated OCI(1.2M)(12.54M)(441K)(1.52M)2.19M
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.29B1.1B811.02M1.54B1.19B
Total Debt97.09M85.66M72M56.99M62.02M
Net Debt(106.03M)(53.6M)(16.21M)(19.26M)(27.11M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$113.6M
Short-term Investments$623.4M
Receivables$16.1M
Inventory$35.1M
Other Current$46.6M
Total Current Assets$834.8M
PP&E (Net)$37.8M
Long-term Investments$308.5M
Other Non-current$3.9M
Total Non-current Assets$350.1M
Total Assets$1.2B

Analysis

Selected assets total $1.2B for Latest. The largest visible component is Short-term Investments at $623.4M, about 52.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 13, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 28, 2026
4Statement of changes in beneficial ownershipOct 23, 2026

How much cash does AGIO have?

Agios Pharmaceuticals, Inc. (AGIO) reported $89.13M in cash and equivalents in fiscal 2025.

How much debt does AGIO carry?

Agios Pharmaceuticals, Inc. (AGIO) reported $62.02M of total debt, with net debt of -$27.11M.